Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Pyxis Oncology, Inc. (PYXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| Wadhane Jitendra (Chief Accounting Officer) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 2,500 shares
@ $1.87, valued at
$4.7k
|
|
| 09/27/2023 |
4
| Connealy Pamela Ann (CFO and COO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 6,426 shares
@ $1.8468, valued at
$11.9k
|
|
| 09/26/2023 |
4
| Dupont Jakob (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 392,461 options to buy
@ $1.6, valued at
$627.9k
|
|
| 08/25/2023 |
4
| Dupont Jakob (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 5,879 options to buy
@ $26.61, valued at
$156.4k
Granted 3,534 options to buy
@ $26.61, valued at
$94k
Granted 17,250 options to buy
@ $15.37, valued at
$265.1k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| PFIZER INC (10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 1,811,594 shares
@ $2.76, valued at
$5M
|
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| BARCLAYS PLC (10% Owner) has filed a Form 4 on Pyxis Oncology, Inc. |
| 04/25/2022 |
4
| Chin Mark (Former Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Sold 1,745,761 shares
@ $3.05, valued at
$5.3M
|
|
| 04/15/2022 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 93,493 shares
@ $0 |
|
| 04/15/2022 |
4
| Feingold Jay (Chief Medical Officer) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 115,931 shares
@ $0 |
|
| 04/15/2022 |
4
| Sullivan Lara (CEO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 315,273 shares
@ $0 |
|
| 04/04/2022 |
4
| FLAVIN JOHN L (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 04/04/2022 |
4
| Feingold Jay (Chief Medical Officer) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 306,930 shares
@ $0 |
|
| 04/04/2022 |
4
| Sullivan Lara (CEO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 742,574 shares
@ $0 |
|
| 04/04/2022 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 04/04/2022 |
4
| Cline Darren S (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 04/04/2022 |
4
| Chin Mark (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 04/04/2022 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 247,524 shares
@ $0 |
|
| 04/04/2022 |
4
| Lewis-Hall Freda C (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Yanchik Connealy Pamela (CFO) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 52,944 options to buy
@ $9.64, valued at
$510.4k
|
|
|
|
|